HK Stock MarketDetailed Quotes
02563 BIOSTAR PHARM-B
- 31.250
- +0.550+1.79%
Market Closed Dec 13 16:08 CST
11.39BMarket Cap-63.26P/E (TTM)
31.500High30.400Low396.20KVolume30.700Open30.700Pre Close12.21MTurnover0.18%Turnover RatioLossP/E (Static)364.59MShares31.50052wk High15.45P/B6.77BFloat Cap19.48052wk Low--Dividend TTM216.72MShs Float31.500Historical High--Dividend LFY3.58%Amplitude19.480Historical Low30.815Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
BIOSTAR PHARM-B Key Stats
EPS
According to the latest financial report of BIOSTAR PHARM-B, the latest earnings per share (TTM) for the company is -0.60. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: HKD
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out BIOSTAR PHARM-B's latest financial report to see how much their book value per share (BVPS) is currently at --.
Currency: HKD
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of BIOSTAR PHARM-B shows that the company's current ratio is 14.48, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of BIOSTAR PHARM-B, the quick ratio is 13.86, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of BIOSTAR PHARM-B? The latest ROE figure is -23.65%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of BIOSTAR PHARM-B, the total asset return on investment (ROA) is -22.15%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check BIOSTAR PHARM-B's latest financial report to see how their gross margin is doing - currently at 70.27%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of BIOSTAR PHARM-B, the net profit margin is -284.60%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
HK
Overall
Symbol
Price
% Chg
No Data
